Literature DB >> 22954974

Pituitary dysfunction in survivors of spontaneous subarachnoid hemorrhage of anterior communicating artery and middle cerebral artery aneurysms: A comparative study.

Pinaki Dutta1, Kanchan K Mukherjee, Prashant K Chaudhary, Shriq Rashid Masoodi, Srinivasan Anand, Ashis Pathak, Viral N Shah, Suresh Narain Mathuriya.   

Abstract

BACKGROUND: The data on incidence of hypopituitarism after SAH are conflicting. Furthermore, it is still not known whether there is any difference in hormonal deficiencies between SAH due to anterior communicating artery (A-com) and middle cerebral artery (MCA) aneurysms.
MATERIALS AND METHODS: This study includes both retrospective and prospective arms. The data collected included baseline demographic profile, clinical severity on admission to the hospital by the Hunt and Hess grading system and World Federation of Neurological Surgeons (WFNS) grading, radiological severity of bleed by the Fisher's classification, and treatment details. All the patients underwent detailed hormonal evaluation at baseline and 6 months in prospective group while at the end of 1 year in the retrospective group. Hormonal deficiencies between patients with A-com and MCA aneurysmal SAH were compared using appropriate statistical tests.
RESULTS: Of 60 patients studied, 47 patients (A-com: 28 and MCA: 19) were in the retrospective group, while 13 patients (A-com-9, MCA-4) were in the prospective group. The baseline data were comparable between the two groups. At or after 6 months follow-up, 19 (31.6%) patients, 10 patients with A-com and 9 patients with MCA aneurysmal SAH, had some form of hormone deficiency. Furthermore, there was no difference in endocrine dysfunctions between the two groups. There was no correlation between the severity of hormonal deficiency and the clinical severity of SAH grade by Hunt and Hess and radiological grade of SAH by Fisher's grade.
CONCLUSION: Hormonal deficiencies are not uncommon in patients with SAH. There is no difference in hormonal deficiencies and severity of hypopituitarism in patients with SAH due to A-com and MCA bleed.

Entities:  

Mesh:

Year:  2012        PMID: 22954974     DOI: 10.4103/0028-3886.100729

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  5 in total

1.  Effect of thyroid hormone replacement therapy on cognition in long-term survivors of aneurysmal subarachnoid hemorrhage.

Authors:  Jun Ma; Xinjian Yang; Hao Yin; Yang Wang; Hongbin Chen; Chuangxi Liu; Guoqiang Han; Fangyou Gao
Journal:  Exp Ther Med       Date:  2015-05-07       Impact factor: 2.447

Review 2.  Clinical prevalence and outcome impact of pituitary dysfunction after aneurysmal subarachnoid hemorrhage: a systematic review with meta-analysis.

Authors:  Chiara Robba; Susanna Bacigaluppi; Nicola Bragazzi; Andrea Lavinio; Mark Gurnell; Federico Bilotta; David K Menon
Journal:  Pituitary       Date:  2016-10       Impact factor: 4.107

3.  Pituitary dysfunction after aneurysmal subarachnoid haemorrhage: course and clinical predictors—the HIPS study.

Authors:  L Khajeh; K Blijdorp; M H Heijenbrok-Kal; E M Sneekes; H J G van den Berg-Emons; A J van der Lely; D W J Dippel; S J C M M Neggers; G M Ribbers; F van Kooten
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-11-06       Impact factor: 10.154

Review 4.  Hypopituitarism after subarachnoid haemorrhage, do we know enough?

Authors:  Ladbon Khajeh; Karin Blijdorp; Sebastian Jcmm Neggers; Gerard M Ribbers; Diederik Wj Dippel; Fop van Kooten
Journal:  BMC Neurol       Date:  2014-10-14       Impact factor: 2.474

5.  The prevalence of growth hormone deficiency in survivors of subarachnoid haemorrhage: results from a large single centre study.

Authors:  Sumithra Giritharan; Joanna Cox; Calvin J Heal; David Hughes; Kanna Gnanalingham; Tara Kearney
Journal:  Pituitary       Date:  2017-12       Impact factor: 4.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.